About: Thymoglobulin

An Entity of Type: Food, from Named Graph: http://dbpedia.org, within Data Space: dbpedia.org

Thymoglobulin (manufactured by Sanofi) is an anti-human thymocyte immunoglobulin preparation made of purified polyclonal antibodies derived from rabbits. While these antibodies have a variety of specificities, their main mechanism of immunosuppression is through depletion of T cells. Thymoglobulin is currently approved for clinical use in Europe and the United States for renal allograft rejection, prevention of graft-vs.-host disease, and conditions involving bone marrow failure, including aplastic anemia and has additional off-label uses.

Property Value
dbo:abstract
  • Thymoglobulin (manufactured by Sanofi) is an anti-human thymocyte immunoglobulin preparation made of purified polyclonal antibodies derived from rabbits. While these antibodies have a variety of specificities, their main mechanism of immunosuppression is through depletion of T cells. Thymoglobulin is currently approved for clinical use in Europe and the United States for renal allograft rejection, prevention of graft-vs.-host disease, and conditions involving bone marrow failure, including aplastic anemia and has additional off-label uses. (en)
  • 抗ヒト胸腺細胞ウサギ免疫グロブリン(こうヒトきょうせんさいぼうウサギめんえきグロブリン)とは、ウサギの抗ヒト胸腺細胞グロブリン(ATG)製剤である。再生不良性貧血の治療や臓器移植後の拒絶反応の抑制(ステロイド剤の効果が不充分な場合等)に用いられる。日本においてはサノフィ株式会社がサイモグロブリンとして販売を行っている。 (ja)
dbo:wikiPageID
  • 46361382 (xsd:integer)
dbo:wikiPageLength
  • 6448 (xsd:nonNegativeInteger)
dbo:wikiPageRevisionID
  • 995338669 (xsd:integer)
dbo:wikiPageWikiLink
dbp:wikiPageUsesTemplate
dcterms:subject
gold:hypernym
rdf:type
rdfs:comment
  • Thymoglobulin (manufactured by Sanofi) is an anti-human thymocyte immunoglobulin preparation made of purified polyclonal antibodies derived from rabbits. While these antibodies have a variety of specificities, their main mechanism of immunosuppression is through depletion of T cells. Thymoglobulin is currently approved for clinical use in Europe and the United States for renal allograft rejection, prevention of graft-vs.-host disease, and conditions involving bone marrow failure, including aplastic anemia and has additional off-label uses. (en)
  • 抗ヒト胸腺細胞ウサギ免疫グロブリン(こうヒトきょうせんさいぼうウサギめんえきグロブリン)とは、ウサギの抗ヒト胸腺細胞グロブリン(ATG)製剤である。再生不良性貧血の治療や臓器移植後の拒絶反応の抑制(ステロイド剤の効果が不充分な場合等)に用いられる。日本においてはサノフィ株式会社がサイモグロブリンとして販売を行っている。 (ja)
rdfs:label
  • 抗ヒト胸腺細胞ウサギ免疫グロブリン (ja)
  • Thymoglobulin (en)
owl:differentFrom
owl:sameAs
prov:wasDerivedFrom
foaf:isPrimaryTopicOf
is dbo:wikiPageRedirects of
is dbo:wikiPageWikiLink of
is foaf:primaryTopic of
Powered by OpenLink Virtuoso    This material is Open Knowledge     W3C Semantic Web Technology     This material is Open Knowledge    Valid XHTML + RDFa
This content was extracted from Wikipedia and is licensed under the Creative Commons Attribution-ShareAlike 3.0 Unported License